Session V: Ovarian Cancer III: Novel Therapies
* Emerging options in antiangiogenic targeted therapy for ovarian cancer
Andrew Clamp, MD, PhD
* Targeted therapy for ovarian cancer: Beyond angiogenesis
Stanley B. Kaye, MD
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.